How we focus our attention before we even see an object matters. For example, when we look for something moving in the sky, ...

Welcome to this afternoon session with Recursion. My name is Andrew Pucher. I'm part of the Healthcare Investment Banking team, and I'm joined by Ben Taylor, CFO of Recursion; and Sara Sherman, Head ...

in this video, we will understand what is Recurrent Neural Network in Deep Learning. Recurrent Neural Network in Deep Learning is a model that is used for Natural Language Processing tasks. It can be ...

Breast cancer types include IDC, ILC, HR+, HER2-positive, and triple-negative, each with distinct characteristics and treatment implications. Staging from 0 to IV helps determine treatment plans and ...

Share on Pinterest Experimental vaccine prevents colorectal, pancreatic cancer recurrence in early trial. Image credit: Alina Kostrytsia/Getty Images Gastrointestinal cancers — including pancreatic, ...

New research shows that exercise-based cardiac rehab offers real benefits for people with atrial fibrillation, reducing the risk of recurrence and improving mental well-being, highlighting the need ...

A new drug usually starts with a tragedy. Peter Ray knows that. Born in what is now Zimbabwe, the child of a mechanic and a radiology technician, Ray fled with his family to South Africa during the ...

Hepatocellular carcinoma (HCC), the most prevalent form of primary liver cancer, remains a leading cause of cancer-related mortality worldwide. Although radiofrequency ablation (RFA) is the first-line ...

The benefit of the addition of perioperative pembrolizumab to standard care with surgery and adjuvant therapy for patients with locally advanced head and neck squamous-cell carcinoma (HNSCC) is ...

Recursion Pharmaceuticals announces a workforce reduction of approximately 20%. The Nvidia-backed company expects the move to extend its cash runway into the fourth quarter of 2027. Get more ...

Perioperative FLOT (fluorouracil, leucovorin, oxaliplatin, and docetaxel) is a standard therapy for resectable gastric and gastroesophageal junction adenocarcinomas, but recurrence rates remain high.